Mallinckrodt Hospital recalls Terlivaz (terlipressin for injection) 0.85mg/vial single-dose vials due to temperature excursions during shipping. Affected lots were distributed by Mallinckrodt Hospital Products Inc. in the US.
cGMP deviations: Temperature excursion due to shipping delay from manufacturer to distributor. Affected distributor has been notified.
Mallinckrodt Hospital is recalling Terlivaz (terlipressin for injection) vials that may have been exposed to incorrect temperatures during shipping. This could potentially affect the drug's safety and effectiveness, but the recall does not indicate immediate harm to users.
The recall is due to temperature excursions during shipping from the manufacturer to the distributor. This could mean the medication was exposed to temperatures outside the safe range, potentially affecting its stability and effectiveness. However, the recall does not indicate that the medication caused harm to users.
Healthcare providers and patients who have been prescribed Terlivaz (terlipressin for injection) 0.85mg/vial single-dose vials with lot number 22TRP01-F2. Those using the medication for medical purposes are most at risk.
Check for Terlivaz (terlipressin for injection) 0.85mg/vial single-dose vials with lot number 22TRP01-F2, which were distributed by Mallinckrodt Hospital Products Inc. in the US. The expiration date is June 30, 2024.
Verify the lot number on your Terlivaz vial to see if it matches 22TRP01-F2.
The recall is due to potential temperature issues during shipping, but the official notice does not indicate that the medication caused harm to users.
Check for Terlivaz (terlipressin for injection) 0.85mg/vial single-dose vials with lot number 22TRP01-F2, which were distributed by Mallinckrodt Hospital Products Inc. in the US.
The official notice does not specify a remedy for this recall, so contact your healthcare provider for guidance.
We’ve drafted a message you can send Mallinckrodt Hospital to request your refund or repair — edit it as you like.
Subject: Recall D-0341-2024 — Mallinckrodt Hospital Mallinckrodt Hospital Hello, I own a Mallinckrodt Hospital that is covered by recall D-0341-2024 from Mallinckrodt Hospital. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
